drugset
drugset / Trial / NCT02250248

AttraX® Putty vs. Autograft in XLIF®

NCT02250248 ↗

Completed 45 enrolled NuVasive
RandomizedParallel-groupSingle-blindTreatment

Summary

The objective of this study is to evaluate the clinical success of AttraX Putty as a bone graft substitute for autograft in XLIF procedures.

Timeline

Start
2014-12
Primary completion
2021-05-21
Completion
2021-05-21

Drugs

EvaluationDrugModalityDoseRoute
Comparator AttraX Putty Unknown — —

Indications

lumbar disk degenerative disorder